Table 7.6e

Immunosuppression Use for Maintenance

Prior to Discharge, 1995 to 2004

Recipients with Pancreas After Kidney (PAK) Transplants

  Year of Transplant
1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Functioning Graft at Discharge 60 98 114 140 207 276 289 338 315 382
With Immunosuppression Info 60 94 113 137 204 275 288 337 312 372
Corticosteroids Any in Category 21.7% 86.2% 94.7% 98.5% 89.7% 95.6% 92.7% 89.3% 80.8% 74.2%
Steroids 21.7% 86.2% 94.7% 98.5% 89.7% 95.6% 92.7% 89.3% 80.8% 74.2%
Cyclosporine Any in Category 36.7% 31.9% 20.4% 25.5% 14.2% 13.8% 9.7% 11.3% 8.3% 8.6%
Cyclosporin 35.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Sandimmmune 0.0% 10.6% 3.5% 3.6% 2.5% 2.2% 0.7% 0.6% 0.3% 0.8%
Neoral 1.7% 21.3% 16.8% 21.9% 11.3% 11.6% 8.0% 8.9% 6.1% 5.6%
Gengraf 0.0% 0.0% 0.0% 0.0% 0.5% 0.0% 1.0% 1.8% 1.9% 2.2%
Tacrolimus Any in Category 53.3% 48.9% 78.8% 75.2% 83.3% 85.1% 90.6% 86.4% 80.8% 79.6%
Tacrolimus 53.3% 48.9% 78.8% 75.2% 83.3% 85.1% 90.6% 86.4% 80.8% 79.6%
Antimetabolites Any in Category 88.3% 90.4% 92.9% 90.5% 84.8% 82.2% 75.0% 73.9% 85.6% 80.6%
Mycophenolate Mofetil 11.7% 78.7% 91.2% 86.1% 81.4% 80.4% 73.6% 73.6% 84.9% 79.6%
Mycophenolate Sodium 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.8%
Azathioprine 76.7% 11.7% 1.8% 4.4% 3.4% 1.8% 1.4% 0.3% 0.6% 0.3%
mTOR Inhibitors Any in Category 0.0% 0.0% 0.0% 0.7% 1.5% 8.4% 21.9% 19.3% 14.7% 15.9%
Sirolimus 0.0% 0.0% 0.0% 0.7% 1.5% 8.4% 21.9% 19.3% 14.7% 15.9%
Everolimus 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%


Source: OPTN/SRTR Data as of May 2, 2005.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients maybe prescribed more than one drug within the same category.